Real-Time PCR Assay for Rapid and Simultaneous Detection of <i>vanA</i> and <i>vanB</i> Genes in Clinical Strains

Here, we develop a robust and sensitive real-time PCR assay which allows the simultaneous detection of <i>vanA</i> and <i>vanB</i> genes using common primers. The system was designed using the Primer3 online software. The specificity of primers and probes was first checked by...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hanane Zerrouki, Sid-Ahmed Rebiahi, Linda Hadjadj, Jean-Marc Rolain, Seydina M. Diene
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/e5046a47ba044f1b92f8de98b7730ef0
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
Descripción
Sumario:Here, we develop a robust and sensitive real-time PCR assay which allows the simultaneous detection of <i>vanA</i> and <i>vanB</i> genes using common primers. The system was designed using the Primer3 online software. The specificity of primers and probes was first checked by in silico PCR and by BlastN analysis. The genomic DNA of 255 bacterial isolates, including <i>Enterococcus</i> spp., Gram-negative, and Gram-positive strains, as well as a collection of 50 stool and 50 rectal swab samples, were tested to evaluate the specificity of the new real-time PCR (RT-PCR) system. The results of the designed RT-PCR were 100% specific and 100% positive on tested vancomycin resistant isolates harboring either the <i>vanA</i> or <i>vanB</i> gene. RT-PCR assays were negative for all other bacterial species tested including vancomycin-sensitive <i>Enterococci</i> and <i>Enterococcus</i> strains harboring <i>vanC</i> genes. The limit of detection of <i>vanA</i> and <i>vanB</i> genes by RT-PCR assay was 47 CFU/mL and 32 CFU/mL, respectively. The rapid and accurate detection of vancomycin-resistant Enterococci is the cornerstone for minimizing the risk of nosocomial transmissions and outbreaks. We believe that this assay will strengthen routine diagnostics and surveillance programs.